The Study of Liophilization Parameters in the Liposomal Irinotecan Development

Vìsnik farmacìï
doi 10.24959/nphj.17.2182
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National University of Pharmacy

Related search

Quality of Life in Metastatic Pancreatic Cancer Patients Receiving Liposomal Irinotecan Plus 5-Fluorouracil and Leucovorin

European Journal of Cancer
Cancer ResearchOncology
2019English

Liposomal Irinotecan and 5-Fluorouracil/Leucovorin in Older Patients With Metastatic Pancreatic Cancer – A Subgroup Analysis of the Pivotal NAPOLI-1 Trial

Journal of Geriatric Oncology
GerontologyGeriatricsOncology
2019English

Development and in Vitro Characterisation of a Benznidazole Liposomal Formulation

International Journal of Pharmaceutics
Pharmaceutical Science
2002English

Formulation Development and Evaluation of Liposomal Gel for the Treatment of Ulcerative Colitis

Journal of Pharmaceutical & Scientific Innovation
2018English

Immunological Parameters Associated With the Development of Allergic Rhinitis: A Preliminary Prospective Study

American Journal of Rhinology and Allergy
MedicineOtorhinolaryngologyAllergyImmunology
2012English

Predictive Value of Heidelberg Retina Tomograph Parameters for the Development of Glaucoma in the European Glaucoma Prevention Study

American Journal of Ophthalmology
Ophthalmology
2015English

P2.12-04 Liposomal Irinotecan vs Topotecan in Patients With Small Cell Lung Cancer Who Have Progressed on/After Platinum-Based Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Case-Study Investigating the Physicochemical Characteristics That Dictate the Function of a Liposomal Adjuvant

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Development of PEG-Liposomal Formulation Encapsulating Anti-Cancer Drugs

MEMBRANE
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy